on the role of TRPV4 in cardiomyocytes. Our data show that TRPV4 protein expression increases in cardiomyocytes of the aged heart. The objective of this study was to examine the role of TRPV4 in cardiomyocyte Ca 2þ homeostasis following hypoosmotic stress and to assess the contribution of TRPV4 to cardiac contractility and tissue damage following ischaemia-reperfusion (I/R), a pathological condition associated with cardiomyocyte osmotic stress. 
Methods and results
TRPV4 protein expression increased in cardiomyocytes of Aged (24-27 months) mice compared with Young (3-6 months) mice. Immunohistochemistry revealed TRPV4 localization to microtubules and the t-tubule network of cardiomyocytes of Aged mice, as well as in left ventricular myocardium of elderly patients undergoing surgical aortic valve replacement for aortic stenosis. Following hypoosmotic stress, cardiomyocytes of Aged, but not Young exhibited an increase in action-potential induced Ca 2þ transients. This effect was mediated via increased sarcoplasmic reticulum Ca 2þ content and facilitation of Ryanodine Receptor Ca 2þ release and was prevented by TRPV4 antagonism (1 lmol/L HC067047). A similar hypoosmotic stress-induced facilitation of Ca 2þ transients was observed in Young transgenic mice with inducible TRPV4 expression in cardiomyocytes. Following I/R, isolated hearts of Young mice with transgenic TRPV4 expression exhibited enhanced contractility vs. hearts of Young control mice. Similarly, hearts of Aged mice exhibited enhanced contractility vs. hearts of Aged TRPV4 knock-out (TRPV4-/-) mice. In Aged, pharmacological inhibition of TRPV4 (1 lmol/L, HC067047) prevented hypoosmotic stress-induced cardiomyocyte death and I/R-induced cardiac damage.
Introduction
The functional properties of the heart change with advancing age in part due to alterations in cardiomyocyte excitation-contraction coupling (ECC). 1 ECC is a precisely co-ordinated series of cellular processes initiated by cardiomyocyte depolarization, which opens L-Type Ca 2þ channels (LTCC) on the surface sarcolemma and triggers Ca 2þ release from Ryanodine Receptor (RyR) channels of the sarcoplasmic reticulum (SR) Ca 2þ store (for review, see ref.
2 :Na þ permeability ratio 15 ) and was originally described as a cellular osmosensor responsive to hypoosmotic stress. 16 Subsequent studies revealed a more diverse role for TRPV4 in cellular Ca 2þ homeostasis, and TRPV4 is now believed to be a multi-modal ion channel responsive to cellular stimuli including mechanical stretch, temperature, shear stress, and intracellular signalling molecules. 17 Considering that TRPV4 has a high single-channel conductance (50-100 pS 15 ) and exhibits coupled-gating behaviour, 18 it represents an attractive ion channel target to prevent cellular Ca 2þ overload and cell death. [19] [20] [21] Despite the expansive literature on TRPV4 in many muscle cell types, TRPV4 expression and function in adult cardiomyocytes remains unclear. 22, 23 In this investigation, we test the hypothesis that TRPV4 contributes to cardiomyocyte Ca 2þ entry and enhances cardiomyocyte ECC following hypoosmotic stress in the aged heart. We show that TRPV4 protein expression increases in cardiomyocytes of Aged (24-27 months) mice. Elevated expression of TRPV4 in cardiomyocytes, either endogenously in Aged mice or in Young mice with transgenic expression of TRPV4, enhances Ca 2þ transients following hypoosmotic stress. Further, following ischaemia-reperfusion (I/R) injury (a pathological condition associated with pronounced osmotic stress on cardiomyocytes), TRPV4 contributes to hypercontractility and tissue damage. The TRPV4 ion channel may therefore represent a critical regulator of Ca 2þ homeostasis in cardiomyocytes of the aged heart, and TRPV4 inhibition may provide benefit following myocardial infarction in elderly populations. Previous reports of this work have been presented in abstract form.
24,25
2. Methods
Animals
Procedures were approved by the Animal Care and Use Committee at the University of Missouri and complied with all US and UK regulations involving animal experimentation. C57BL/6, TRPV4(-/-), 26 transgenic MerCreMer 27 Â Tg( aMHC-loxP-mCherrySTOP-loxP-TRPV4)1td, and
MerCreMer Â Tg(CAG-loxP-STOP-loxP-TRPV4-mCherry)1td mice were studied at ages of 3-6 (defined as Young) or 24-27 months (defined as Aged). Mice were anaesthetized with an intraperitoneal injection of sodium pentobarbital (60 mg/kg), and hearts were rapidly ($30 s) excised for subsequent experimentation.
Human tissue samples
Myocardial tissue was obtained from the basal septum of the left ventricle in patients undergoing surgical aortic valve replacement for aortic stenosis. Immunohistochemistry was performed on formalin fixed, paraffin embedded specimens. Written informed consent was obtained from all patients under an Institutional Review Board approved protocol, 28 and conform to the declaration of Helsinki. 
Solutions
Isosmotic ($300 mOsm/L, ISO) Physiological
Immunoassays
Western blotting and immunohistochemistry were performed with anti-TRPV4 (1:100-1:500 Biorbyt, orb215251), anti-Caveolin-3 
Cardiomyocyte functional experiments
Intracellular Ca 2þ (fluo-4/AM or fluo-5F/AM) was monitored in electrically-stimulated (0.5 Hz) isolated cardiomyocytes at 25 C using laser-scanning confocal fluorescence microscopy. 29 For the cardiomyocyte damage assay, cells were exposed to hypoosmotic stress and electrically stimulated (1 Hz, 37 C) for 1 h to assess the percent of cells TRPV4 and cardiomyocyte calcium in the aged heart exhibiting irreversible contracture and damage (see Supplementary material online for additional details).
Isolated heart experiments
Left ventricular pressure development was monitored using a 1 F tip Millar catheter in Langendorff perfused hearts (60 mmHg afterload, 37 C). Pressure development and rate were assessed at sinus rhythm under control conditions, during global ischaemia (45 min), and during reperfusion (2 h). A subset of hearts was perfused with 1% triphenyltetrazolium chloride (TTC) following reperfusion to assess metabolically active (red) vs. inactive (white) tissue. Pressure waveform selection criteria are described in detail in Supplementary material online.
Statistical analysis
All data are reported as individual observations or means ± standard error. Summary data were analysed using t-tests, two-way ANOVA, or two-way repeated measures ANOVA (Bonferroni post hoc) where appropriate based on experimental design. Data are reported as statistically significant at P < 0.05 (* or # ), P < 0.01 (** or ## ), and P < 0.01 (*** or ### ) levels.
Results
TRPV4 protein expression was monitored using western blot analysis of isolated left-ventricular cardiomyocyte homogenates from Young and Aged C57BL/6 mice, and indicated a significant increase in TRPV4 protein in Aged ( Figure 1A and B). Immunocytochemistry ( Figure 1C ) revealed subcellular localization of TRPV4 in perinuclear regions and along the microtubule network (colocalization with a-tubulin, Figure 1D ), as well as within the t-tubule network (colocalization with Caveolin-3, Figure 1E ). TRPV4 localization was confirmed in live cells via transgenic expression of a TRPV4-mCherry fusion protein (see Supplementary material online, Figure S1A and B), and colocalization was observed between mCherry and SiR Tubulin and mCherry and the membrane dye CellMask Deep Red (see Supplementary material online, Figure S1C ). Similar to findings observed in Aged mice ( Figure 1F ), TRPV4 protein was also detected in left ventricular tissue sections of elderly patients (n = 14, 57-87 years of age) obtained from the basal septum during surgical aortic valve replacement ( Figure 1G) . TRPV4 is well-described as a Ca 2þ influx channel responsive to hypoosmotic stress. 16, 17 We, therefore, explored the functional role of Table S1 ), and these effects were prevented by the TRPV4 antagonist HC067047 (HC, 1 lmol/L). The TRPV4 antagonist did not affect Ca 2þ transient parameters in Aged in the absence of hypoosmotic stress, and was without effect in Young under any experimental condition. In mouse ventricular cardiomyocytes the majority ($90%) of the Ca 2þ transient is due to Ca 2þ release from the SR via RyR release channels, which in turn is highly dependent on SR Ca 2þ content. 30 To assess the mechanisms by which TRPV4 augments Ca 2þ transients in Aged following hypoosmotic stress, we monitored the frequency of spontaneous RyR Ca 2þ sparks following rest from action-potential stimulation. Ca 2þ spark frequency was low under isosmotic conditions ( Figure 2C , upper) but increased following hypoosmotic stress ( Figure 2C , lower). The increase in Ca 2þ sparks observed following hypoosmotic stress was prevented by TRPV4 inhibition with HC067047 ( Figure 2D Figure 2E , denoted by bars) was elevated following hypoosmotic compared with isosmotic conditions, and this effect was prevented by TRPV4 inhibition with HC067047 ( Figure 2F) . Taken together, these data suggest that TRPV4 contributes to cellular and SR Ca 2þ loading following hypoosmotic stress, with a subsequent increase in SR Ca 2þ release during ECC.
Advancing age associates with numerous alterations in Ca 2þ handling protein expression and function. We, therefore, evaluated the effect of increased TRPV4 expression on cardiomyocyte Ca 2þ homeostasis, independent of advancing age, using a double-transgenic (DTg), Tg(aMHCloxP-mCherrySTOP-loxP-TRPV4)1td Â aMHC-MerCreMer mouse ( Figure 3A ) with tamoxifen-inducible, cardiac-specific TRPV4 expression. Induction of TRPV4 transgene expression in Young mice resulted in TRPV4 protein levels $2-fold greater than those observed endogenously in Aged mice ( Figure 3D ). Consistent with observations in Aged C57BL/6 mice, cardiomyocytes of Young DTg mice exhibited an increase in Ca 2þ transient amplitude following hypoosmotic stress, which was prevented by TRPV4 inhibition ( Figure 3E and F). These effects were absent in Young DTg mice not fed tamoxifen, and absent in tamoxifenfed aMHC-MerCreMer single transgenic mice (combined controls DF/F 0 , ISO: 1.78 ± 0.11 vs. DF/F 0 , HYPO: 1.78 ± 0.07).
A pathological scenario associated with pronounced cardiomyocyte hypoosmotic stress is I/R injury. 31 Therefore, we examined the role of In addition, the reperfusion-induced change in contractile function in Aged C57BL/6 was prevented by TRPV4 inhibition with 1 lmol/L HC067047 (see Supplementary material online, Figure S3 ). The enhanced contractile function observed in early reperfusion in Young DTg and Aged mice was not sustained 2 h after reperfusion (see Supplementary material online, Table S2 ). Taken together, these data identify cardiomyocyte TRPV4 as a novel mediator of enhanced contractile function early in I/R. Excessive Ca 2þ entry into cardiomyocytes is an established cause of cardiomyocyte necrosis and tissue damage following I/R. 4 We, therefore, examined if TRPV4 inhibition reduces hypoosmotic stress-induced damage in isolated cardiomyocytes and I/R-induced cardiac damage in Langendorff-perfused hearts of Aged mice (corresponding to the population at high risk of myocardial infarction Figure 6A and B) . Langendorff-perfused hearts were subjected to global I/R (45 min ischaemia, 2 h of reperfusion) and perfused with TTC to differentiate metabolically active vs. inactive tissue ( Figure 6C) , and under these conditions hearts of Aged mice exhibited a 20% loss of viable cardiac tissue. In contrast, hearts of Aged mice treated with the TRPV4 antagonist HC067047 exhibited only a 6% loss of viable tissue ( Figure 6D) . Taken together, these data are consistent with TRPV4 
Discussion

TRPV4 channel expression in cardiomyocytes
The TRP ion channel superfamily has recently been appreciated as a prominent mediator of signal transduction within cardiomyocytes, and the present investigation adds to this emerging literature by providing the first description of the functional role of TRPV4 in cardiomyocytes of the aged heart. While organ-level TRPV4 expression in the heart is wellestablished, cell types known to express TRPV4 (including cardiac fibroblasts, vascular endothelial cells, and vascular smooth muscle cells) collectively far outnumber cardiomyocytes within the heart, and therefore, expression of TRPV4 in cardiomyocytes remains unclear. 22, 32 Recent data in whole-heart homogenates of young mice subjected to pressure overload 33 or ischaemia-reperfusion injury 34, 35 show an increase in TRPV4 expression following pathological stimuli. While these findings suggest a change in TRPV4 expression in cardiomyocytes, changes in TRPV4 expression in other cell types (most notably fibroblasts 36 ) may also underlie such findings. Our data reveal that with advancing age TRPV4 expression and function increases and exerts significant effects on cardiomyocyte Ca 2þ homeostasis and contractile function. Further, signal amplification via co-operative gating behaviour. 18 Increased TRPV4 activity may also lead to cytosolic Na þ accumulation, either directly through the channel or secondary to the elevation in Ca 2þ via enhanced diastolic forward-mode NCX activity. During systole, elevated cytosolic Na þ favours reverse-mode NCX Ca 2þ entry at the peak of the actionpotential, which increases the amplitude of the Ca 2þ transient, 37 and such a mechanism has been proposed to underlie augmentation of ECC following TRPC channel activation. RyR activity. 40 Although we only examined acute activation of TRPV4 in the present investigation, sustained TRP channel activity may also lead to phosphorylation of RyR by Ca 2þ /calmodulin-dependent protein kinase II, 39 resulting in SR Ca 2þ leak and a cellular phenotype of enhanced RyR Ca 2þ spark frequency with no change (or even a decrease) in SR Ca 2þ content. Therefore, TRP channel activation may lead to complex timedependent changes, with initial enhancement of ECC followed by a secondary deterioration in function.
TRPV4-mediated contractile function and cardiomyocyte death following I/R
Excessive cardiomyocyte Ca 2þ entry and adverse Ca 2þ overload during I/R are classically believed to be pH-driven processes (for reviews, see refs 41, 42 ). During ischaemia, cardiomyocytes shift energy production from oxidative phosphorylation to anaerobic glycolysis with concomitant lactic acid accumulation and intracellular acidification. 43 During reperfusion the extracellular environment is rapidly restored creating a large outward H þ gradient which drives sequential Na þ /H þ and Na þ / Ca 2þ exchange and an elevation in intracellular Ca 2þ (Figure 7 , right).
Our data in Aged mice reveal a novel osmolarity-induced Ca 2þ signalling pathway via TRPV4 in cardiomyocytes (Figure 7 , left). We propose that during ischaemia, both the intracellular and extracellular environment gradually develop an increase in osmolarity 31 yet osmotic stress on the cardiomyocyte membrane is minimal due to equilibration between the intracellular and extracellular compartments. During reperfusion, however, rapid washout of the extracellular fluid creates a marked hypoosmotic stress on the cardiomyocyte sarcolemma which activates TRPV4 and additional Ca 2þ entry. The combination of pH-driven and osmolarity-driven Ca 2þ entry leads to enhanced Ca 2þ cycling and contractility in the early stages of reperfusion. However, the pronounced overload, during which mitochondria accumulate excessive amounts of Ca 2þ within the mitochondrial matrix leading to mitochondrial permeability transition (MPT), rapid dissipation of the mitochondrial proton gradient, and mitochondrial depolarization. 42 Further, Ca 2þ overloadinduced MPT ceases ATP production, leads to generation of reactive oxygen species, promotes mitochondrial swelling and rupture, and ultimately leads to cardiomyocyte necrosis and short-term cardiac dysfunction. 4 Consistent with this working model, TRPV4-mediated Ca 2þ entry was recently shown to mediate reactive oxygen species production, MPT, mitochondrial depolarization, and cell death in cultured H9C2 cells following hypoxia-reoxygenation challenge. 20 Therefore, in the intact heart an initial increase in contractility is observed during early reperfusion due to a TRPV4-mediated enhancement of cardiomyocyte Ca 2þ cycling ( Figure 2 ) and contractile strength ( Figure 5) . However, the enhanced contractility is not maintained (see Supplementary material online, Table S2 ) due to cardiomyocyte death ( Figure 6A and B) and cardiac damage ( Figure 6C and D) . In addition to the acute effects on cardiac dysfunction, cardiomyocyte death also activates an inflammatory response leading to a secondary phase of maladaptive remodelling and long-term cardiac dysfunction. This working model is consistent with the literature on short-term benefit/long-term harm with positive inotropes such as catecholamines. b-Adrenergic stimulation enhances Ca 2þ cycling and contractility (a beneficial short-term effect) yet activation of this signalling pathway increases myocardial oxygen demand and leads to Ca 2þ -dependent cardiomyocyte necrosis. 4 For this reason, b-inotropic support is only utilized to treat acute cardiogenic shock following myocardial infarction, and once patients are haemodynamically stable they are prescribed the reciprocal b-blocker treatment which provides longterm clinical benefit. TRPV4 inhibitors may therefore, represent a novel pharmacological approach to prevent excessive contractility, cardiomyocyte Ca 2þ overload, and cardiomyocyte death following I/R.
Acute vs. chronic effects of TRPV4 inhibition following I/R
Our data indicate that TRPV4 is expressed in cardiomyocytes of the aged heart and exerts effects on cardiomyocyte viability in the acute phase (min to h) of I/R. Interestingly, multiple recent investigations report that hearts of young mice exhibit a secondary increase in TRPV4 expression following I/R 20, 35 that may contribute to cardiomyocyte apoptosis, myofibroblast differentiation, fibrosis, 36,44 adverse remodelling, and cardiac dysfunction. 20, 35, 45 Taken together, these data suggest that pharmacological therapies which inhibit TRPV4 will exert beneficial effects in both the acute and chronic stages of I/R injury. However, our data highlight the need for immediate treatment with TRPV4 antagonists during reperfusion therapy to prevent acute Ca 2þ -dependent cardiomyocyte damage, and the therapeutic window to obtain maximum clinical benefit may be shorter than previously reported.
Study limitations
Cardiac I/R associates with complex changes in tissue osmolarity, with a gradual increase in osmotically active particles in both the intracellular and extracellular compartments, followed by reperfusion and a rapid reversion of the extracellular environment to normal osmotic conditions with associated hypoosmotic stress on the cardiomyocyte. Given the difficulty in precisely replicating this form of stress in the isolated cell environment, we utilized a defined reduction in osmotically active particles in the extracellular solution to induce hypoosmotic stress on cardiomyocytes. A global I/R protocol was used to examine contractile function and tissue damage in isolated perfused hearts. Unfortunately, this protocol associated with frequent supraventricular tachycardia and other complex arrhythmias, which precluded rigorous classification and quantification of ventricular arrhythmia burden in our experiments. Thus, while Ca 2þ -dependent arrhythmia is well-established following I/R, 41 the specific role of TRPV4 in ventricular arrhythmia post I/R remains to be appropriately tested. Heteromeric assembly of TRPV4 with other TRP channel family members is well-established, 46 including with members known to be expressed in cardiomyocytes such as TRPV2 and TRPC6. It is, therefore, plausible that TRPV4 inhibition may prevent ion flux through multiple TRP channels, as has been shown with dominantnegative TRPC expression in cardiomyocytes. 10 ,39 TRPV4 antagonists exhibit excellent pharmacological properties in vivo 47 and are currently in clinical trials to improve pulmonary function in heart failure (NCT02119260, NCT02497937). Heteromeric assembly of TRPV4 with other TRP channel members would therefore, be advantageous, as it would allow TRPV4 inhibitors to prevent adverse effects of several TRP channel family members.
Conclusions
TRPV4 is now appreciated as a critical cellular signal integrator. Our working model is that increased TRPV4 expression in the aged heart is a physiological adaptation that enhances Ca 2þ cycling and contributes to processes such as cardiac mechanotransduction, cell volume regulation, or Ca 2þ -dependent hypertrophic remodelling. However, during I/R, physiological TRPV4-mediated Ca 2þ signal transduction transitions into pathological Ca 2þ signal overload. When combined with pH-driven Ca 2þ entry processes, TRPV4-mediated Ca 2þ entry leads to excessive contractility and adverse tissue damage. Over 50% of all hospital admissions and 80% of deaths due to myocardial infarction occur in elderly individuals. TRPV4 may therefore, represent a novel ion channel target to prevent tissue damage and mortality following myocardial infarction.
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